Tonix Pharma to advance development of its single dose live attenuated virus vaccine, TNX-801, as WHO declares mpox outbreak a global health emergency.
Monkeypox Cases Push TNX-801 Into the Spotlight.
More than 300 cases of monkeypox have been reported recently around the world. Monkeypox is a virus that originates in rodents and primates in West and Central Africa. It occasionally jumps to humans, but cases outside of Africa are rare except for infected travelers and imported animals. Authorities are still unsure what is behind the recent uptick in cases, however it has thrust the potential need for a monkeypox vaccine into the spotlight.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is developing TNX-801, a live form of the horsepox virus, as a preventative for smallpox and monkeypox infection.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
The Straits Times Index (STI) has a long history of performance, with the index first being introduced in 1966.
296Followers
17Following
1896Visitors
Follow